Divested Suanovil 50

Verify with FDA CVM →

111 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
111
Total Reports
18
Deaths Reported
1620.0%
Death Rate

Active Ingredients

Divested Suanovil 50

Administration Routes

UnknownOralIntramuscularAuricular (Otic)Immersion

Species Affected

Dog 89
Cattle 11
Horse 6
Cat 5

Most Affected Breeds

Retriever - Labrador 12
Terrier - Yorkshire 7
Cattle (other) 6
Terrier - Boston 6
Pit Bull 6
Quarter Horse 6
Shepherd Dog - German 6
Retriever - Golden 5
Chihuahua 5
Domestic Shorthair 5

Most Reported Reactions

Vomiting 29
Lethargy (see also Central nervous system depression in 'Neurological') 14
Seizure NOS 13
Death 11
Hyperglycaemia 10
Anorexia 9
Diarrhoea 8
Dehydration 8
Death by euthanasia 7
Elevated serum alkaline phosphatase (SAP) 7
Lack of efficacy - NOS 6
Lack of efficacy (endoparasite) - heartworm 6

Outcome Breakdown

Outcome Unknown
53 (44.9%)
Recovered/Normal
35 (29.7%)
Died
12 (10.2%)
Ongoing
9 (7.6%)
Euthanized
6 (5.1%)
Recovered with Sequela
3 (2.5%)

Data Summary

Metric Value
Total adverse event reports 111
Reports involving death 18
Case-fatality rate (reported events) 1620.0%
Distinct species in reports 4
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Divested Suanovil 50 Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 111 adverse event reports referencing Divested Suanovil 50, including 18 reports in which the animal died — a 1620.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Divested Suanovil 50. Reported administration routes include Unknown, Oral, Intramuscular, Auricular (Otic). These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Divested Suanovil 50 reports are Dog (89 reports), Cattle (11 reports), Horse (6 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (12), Terrier - Yorkshire (7), Cattle (other) (6) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Divested Suanovil 50 are Vomiting (29), Lethargy (see also Central nervous system depression in 'Neurological') (14), Seizure NOS (13), Death (11). Of the 118 reports with a coded outcome, Outcome Unknown is the leading category at 44.9%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Divested Suanovil 50.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial